REGENERATE LIFE NATURALLY Trademark

Trademark Overview


On Tuesday, July 31, 2012, a trademark application was filed for REGENERATE LIFE NATURALLY with the United States Patent and Trademark Office. The USPTO has given the REGENERATE LIFE NATURALLY trademark a serial number of 85691657. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 5, 2020. This trademark is owned by GOLDEN BIOTECHNOLOGY CORPORATION. The REGENERATE LIFE NATURALLY trademark is filed in the Pharmaceutical Products category with the following description:

Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional addit...
regenerate life naturally

General Information


Serial Number85691657
Word MarkREGENERATE LIFE NATURALLY
Filing DateTuesday, July 31, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 5, 2020
Registration Number4401470
Registration DateTuesday, September 10, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 8, 2013

Trademark Statements


Goods and ServicesAdjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for animals; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments. Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceuticals preparations for the treatment of kidney diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 5, 2020
Primary Code005
First Use Anywhere DateTuesday, July 31, 2012
First Use In Commerce DateTuesday, January 8, 2013

Trademark Owner History


Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Taipei City
TW

Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Taipei City
TW

Party NameGOLDEN BIOTECHNOLOGY CORPORATION
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Taipei City
TW

Trademark Events


Event DateEvent Description
Friday, June 5, 2020CANCELLED SEC. 8 (6-YR)
Monday, September 10, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 10, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, August 6, 2013NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, August 5, 2013LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, August 2, 2013ASSIGNED TO LIE
Saturday, July 20, 2013ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 19, 2013STATEMENT OF USE PROCESSING COMPLETE
Wednesday, June 12, 2013USE AMENDMENT FILED
Wednesday, July 10, 2013CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 12, 2013TEAS STATEMENT OF USE RECEIVED
Tuesday, March 5, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 8, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 8, 2013PUBLISHED FOR OPPOSITION
Wednesday, December 19, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 28, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 28, 2012ASSIGNED TO EXAMINER
Thursday, August 9, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 3, 2012NEW APPLICATION ENTERED IN TRAM